Ra Capital Management, L.P. 89bio, Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in 89bio, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 14,175,398 shares of ETNB stock, worth $113 Million. This represents 1.46% of its overall portfolio holdings.
Number of Shares
14,175,398
Previous 14,175,398
-0.0%
Holding current value
$113 Million
Previous $114 Million
7.62%
% of portfolio
1.46%
Previous 1.71%
Shares
9 transactions
Others Institutions Holding ETNB
# of Institutions
158Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$120 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$63.5 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$58.6 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$55.7 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA6.81MShares$54.1 Million1.6% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $369M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...